Expense

HPE Aruba Networking, Juniper Networks, and Cisco Ranked Leaders in ABI Research's Enterprise WLAN Vendor Competitive Assessment

Retrieved on: 
Tuesday, June 27, 2023
Cambium Networks, Bluetooth Low Energy, Enterprise, BLE, Artificial Intelligence for IT Operations, Network as a service, WLAN, Research, Alcatel-Lucent Enterprise, Arista, Capital expenditure, Expense, Parity, CAPEX, Investment, Extreme Networks, Cisco, Artificial intelligence, OPEX, AI, Juniper Networks, Automation, Software, Retail, Network equipment provider, Huawei

"Enterprise WLAN vendors operate in a mature market with many deep-rooted incumbents safeguarding their market share with robust global distributor and reseller channels across various business verticals," says Andrew Spivey, Senior Analyst at ABI Research.

Key Points: 
  • "Enterprise WLAN vendors operate in a mature market with many deep-rooted incumbents safeguarding their market share with robust global distributor and reseller channels across various business verticals," says Andrew Spivey, Senior Analyst at ABI Research.
  • "Vendors looking to expand are required to develop highly optimized end-to-end solutions for the specific vertical they are targeting.
  • These findings are from ABI Research's Enterprise Wi-Fi and WLAN Vendors competitive ranking.
  • This report is part of the company's Wi-Fi & WLAN Technologies & Markets research service research service, which includes research, data, and analyst insights.

Gossip Stone TV Announces the Episode Four of 'The Most Expensive' Show

Retrieved on: 
Thursday, June 8, 2023
Virtual reality, Television, Advertising, Personality, Univers, Kings, Expense

The latest episode features Ahmed Hamdan and new advertising technologies

Key Points: 
  • Marbella, Spain--(Newsfile Corp. - June 8, 2023) - Gossip Stone TV has released episode four of its enthralling show, The Most Expensive , on May 31, 2023.
  • This captivating episode takes viewers across three countries in a single installment, showcasing the convergence of opulent footwear and advertising led by renowned entrepreneur Ahmed Hamdan.
  • In this episode spanning multiple continents, artist and television personality Debbie Wingham embarks on a new exploration from Dubai to her homeland of England, and finally to Spain.
  • Debbie then travels to Marbella, Spain, where she meets a local fashion and advertising entrepreneur, Ahmed Hamdan.

Aridis Pharmaceuticals Announces First Quarter 2023 Financial Results and Business Update

Retrieved on: 
Thursday, June 8, 2023
Biologics license application, US Foods, Community-acquired pneumonia, MSSA, S. aureus, Methicillin, CAP, Infection, MRSA, Clinical trial, Pharmacokinetics, Cystic fibrosis, Hospital-acquired pneumonia, Melinda French Gates, Staphylococcus, Immunotherapy, AstraZeneca, Staphylococcus aureus, Trial of the century, DE, Pseudomonas aeruginosa, Apex, Phase 10, Development, CFF, Bill & Melinda Gates Foundation, Expense, Patient, Immunoglobulin G, Met, VAP, Administration, Cystic Fibrosis Foundation, Ventilator-associated pneumonia, LOS, Bacteria, Gallium, Research, Gates, FDA, HAP, BLA, ICU, Pneumonia, Safety, Pharmaceutical industry, Cryptocurrency, COVID-19, Kermode

LOS GATOS, Calif., June 08, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, today reported financial and corporate results for its first quarter ended March 31, 2023.

Key Points: 
  • LOS GATOS, Calif., June 08, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, today reported financial and corporate results for its first quarter ended March 31, 2023.
  • “Our first quarter results demonstrate the continued progress and momentum of Aridis Pharmaceuticals.
  • First Quarter 2023 Financial Results:
    Cash: Total cash, cash equivalents and restricted cash as of March 31, 2023, were approximately $1.8 million.
  • Change in Other Comprehensive Income: Change in other comprehensive income increased by approximately $861,000 for the quarter ended March 31, 2023 from $0 for the quarter ended March 31, 2022.

The North West Company Inc. Announces First Quarter Earnings and a Quarterly Dividend

Retrieved on: 
Wednesday, June 7, 2023
Food, Tesco international operations, Interest, Canadian Operational Support Command, Mercantile Stores Company, Inc., GAAP, EBIT, Expense, EBITDA, Depreciation, Administration, TSX, Growth, The Company, NWC, Bank, Bookkeeping, Operation

WINNIPEG, Manitoba, June 07, 2023 (GLOBE NEWSWIRE) -- (TSX: NWC): The North West Company Inc. (the "Company" or "North West") today reported its unaudited financial results for the first quarter ended April 30, 2023.

Key Points: 
  • WINNIPEG, Manitoba, June 07, 2023 (GLOBE NEWSWIRE) -- (TSX: NWC): The North West Company Inc. (the "Company" or "North West") today reported its unaudited financial results for the first quarter ended April 30, 2023.
  • Net Earnings Net earnings decreased to $22.2 million compared to $28.2 million last year.
  • Net earnings attributable to shareholders were $20.9 million and diluted earnings per share were $0.43 per share compared to $0.57 per share last year.
  • The Company uses the following non-GAAP financial measures: earnings before interest, income taxes, depreciation and amortization ("EBITDA"), adjusted EBITDA and adjusted net earnings.

Navidea Biopharmaceuticals, Inc. Reports First Quarter 2023 Financial Results and Provides Business Update

Retrieved on: 
Wednesday, June 7, 2023
Research, Clinical Trials, Biotechnology, Other Health, Managed Care, Health, Pharmaceutical, Science, Oncology, Therapy, Biopharmaceutical, Doctor of Philosophy, Marketing, Meilleur, Consultant, Clinical trial, G2G, PET, CRG, UCSD, Keystone, CMO, Biomarker, Associate, Sale, Rheumatoid arthritis, Translation, State Administrative Expenses, CCRA, Expense, FACEP, Political moderate, Medicine, Technetium-99m, Growth, NYSE, Pharmaceutical industry, Management, Patient

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announces, in line with the Company’s Fix, Fund, Propel approach, details related to recently reported financial results for its first quarter ended March 31, 2023 and provides a business update.

Key Points: 
  • Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announces, in line with the Company’s Fix, Fund, Propel approach, details related to recently reported financial results for its first quarter ended March 31, 2023 and provides a business update.
  • (Fix) In the first quarter of 2023, Selling, general and administrative expenses were down 36% compared to the same period in 2022.
  • Other income, net, was $946,000 during the first quarter of 2023 compared to other expense, net, of $8,000 during the same period in 2022.
  • During the first quarters of 2023 and 2022, we recognized interest expense of $263,000 and $4,000, respectively.

Data443 Adds Antivirus and Ransomware Protection to Data Placement Manager (DPM)

Retrieved on: 
Monday, June 5, 2023
Transfer, ATDS, Fintech, Expense, Privacy, RESEARCH, Organization, DPM, RRM, PCMag, CTI, News, PARK, IBN, Cryptocurrency

RESEARCH TRIANGLE PARK, N.C., June 05, 2023 (GLOBE NEWSWIRE) -- via IBN -- Data443 Risk Mitigation, Inc. (OTCPK: ATDS) (“Data443” or the “Company”), a data security and privacy software company for "All Things Data Security," today announces the addition of antivirus and ransomware protection to its Enhanced File Transfer/Managed File Transfer (EFT/MFT) solution, Data Placement Manager (DPM).

Key Points: 
  • RESEARCH TRIANGLE PARK, N.C., June 05, 2023 (GLOBE NEWSWIRE) -- via IBN -- Data443 Risk Mitigation, Inc. (OTCPK: ATDS) (“Data443” or the “Company”), a data security and privacy software company for "All Things Data Security," today announces the addition of antivirus and ransomware protection to its Enhanced File Transfer/Managed File Transfer (EFT/MFT) solution, Data Placement Manager (DPM).
  • These additions are powered by the Company’s Ransomware Recovery Manager (RRM), named “Best for Inexpensive Protection” and “Best for Kiosks” by PC Mag ( PC Magazine Selects Data443’s Ransomware Recovery Manager as One of the Best Ransomware Protections for 2023 - InvestorWire (IW) ).
  • Today’s announcement follows a recent flurry of customer renewals and additional contract wins for the company’s EFT/MFT solution from long-time clients within the fintech sector.
  • That transaction greatly expands the company’s data security and protection capabilities and augments its cyber threat intelligence (CTI) services, solidifying its position as a market leader in the data security and privacy industry.

Max Stock Limited Reports First Quarter 2023 Financial Results

Retrieved on: 
Tuesday, May 23, 2023
Net, Inventory, Maintenance, Comparable, Marketing, Expense, H-2A visa, EBITDA, ILS, TASE, Depreciation, Growth, EPS, Interest expense, Holding company, Video game, Cryptocurrency

CAESAREA, Israel, May 23, 2023 /PRNewswire/ -- Max Stock Limited (TASE: MAXO) (the "Company") today reported financial results for first quarter ended March 31, 2023.

Key Points: 
  • Net income (attributable to shareholders) increased 50.0% to ILS 20.9 million;
    CAESAREA, Israel, May 23, 2023 /PRNewswire/ -- Max Stock Limited (TASE: MAXO) (the "Company") today reported financial results for first quarter ended March 31, 2023.
  • Revenue increased 11.5% to ILS 279.6 million in the first quarter 2023 as compared with revenue of ILS 250.9 million in the first quarter 2022.
  • Gross profit increased 18.4% to ILS 115.8 million in the first quarter 2023 from ILS 97.8 million in the first quarter 2022.
  • The Company will host a conference call on May 23, 2023 at 8:30 a.m. Eastern Standard Time to discuss first quarter fiscal 2023 results ( link ).

Were you the registered owner or lessor of a Tractor that was issued a parking summons from the City of New York between January 1, 2014, and May 2, 2022? If so, you may be entitled to a refund from a class action settlement

Retrieved on: 
Friday, May 19, 2023
Online, Expense, Vexatious litigation, Thomas Street, Tractor, Settlement, City, Supreme court, Court, Post office box, Tobacco Master Settlement Agreement, County, Tobacco, Ridesharing, Pharmaceutical industry, Online shopping, Lease

PHILADELPHIA, May 19, 2023 /PRNewswire/ -- The following statement is being issued by Kroll Settlement Administration regarding the Sysco Metro, NY Inc. Settlement.

Key Points: 
  • PHILADELPHIA, May 19, 2023 /PRNewswire/ -- The following statement is being issued by Kroll Settlement Administration regarding the Sysco Metro, NY Inc. Settlement.
  • The lawsuit is called Sysco Metro v. The City of New York, Index No.
  • 101637/2015, in the Supreme Court of the State of New York, County of New York.
  • Object: You stay in the Settlement but tell the Court why you think the Settlement should not be approved.

Emmaus Life Sciences Reports Q1 2023 Financial Results and Provides Business Update

Retrieved on: 
Monday, May 15, 2023
OTCQX, Sickle cell disease, Kingdom, Expense, Marketing, Bank, Glutamine

TORRANCE, Calif., May 15, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the three months ended March 31, 2023.

Key Points: 
  • TORRANCE, Calif., May 15, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the three months ended March 31, 2023.
  • Net revenues for the three months ended March 31, 2023 were $6.8 million, compared to $3.2 million for same period in 2022.
  • Of the increased expenses in Q1 2023, $1.2 million was attributable to an increase in share-based compensation and $0.9 million to an increase in selling expenses.
  • On March 31, 2023, the company had cash and cash equivalents of $1.8 million, compared with $2.0 million on December 31, 2022.

Altus Power, Inc. Announces First Quarter 2023 Financial Results

Retrieved on: 
Monday, May 15, 2023
Alternative Energy, Energy, Other Energy, Utilities, ASC, Bank statement, Altus, NMCA, Redmi Note 11, Form 10-K, GAAP, Interest expense, Accounting, REC, Entity, Alignment, Mergers and acquisitions, Monte Carlo, Expense, EBITDA, Retirement, PAR, Acquisition, Accretion expense, Depreciation, Engineering, Samsung Galaxy Note 20, Professional, Earnout, Growth, PPA, NYSE, Cryptocurrency, Life insurance, Security (finance), Insurance, Bookkeeping, Bank

Altus Power, Inc. (NYSE: AMPS) (“Altus Power” or the “Company”), the premier independent commercial-scale clean electrification company, today announced its financial results for the first quarter of 2023.

Key Points: 
  • Altus Power, Inc. (NYSE: AMPS) (“Altus Power” or the “Company”), the premier independent commercial-scale clean electrification company, today announced its financial results for the first quarter of 2023.
  • Adjusted EBITDA* during the first quarter of 2023 was $16.0 million, compared to $8.8 million for the first quarter of 2022, a 83% increase.
  • Altus Power ended the first quarter of 2023 with $84.2 million in cash, cash equivalents, and restricted cash, and $868.3 million of total debt.
  • Altus Power reaffirmed 2023 adjusted EBITDA* in the range of $97-103 million, representing 70% growth over 2022 at the midpoint.